Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

33.15
Delayed Data
As of 4:02pm ET
 -0.0867 / -0.26%
Today’s Change
30.89
Today|||52-Week Range
57.81
-7.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues4.0B4.1B4.1B4.3B
 
 
 
 
 
Cost of Goods Sold533.8M502.4M488.5M547.2M
 
 
 
 
 
Depreciation And Amortization92.3M108.2M110.6M160.6M
 
 
 
 
 
 
Operating ExpensesGross Income3.4B3.5B3.5B3.5B
 
 
 
 
 
General Expenses1.6B1.7B1.7B1.9B
 
 
 
 
 
Research And Development488.6M502.8M519.7M643.4M
 
 
 
 
 
Total Operating Expenses2.2B2.3B2.3B2.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.8B1.9B1.8B1.6B
 
 
 
 
 
Interest Expense On Debt6.8M14.9M--35.0M
 
 
 
 
Other Expenses-7.2M40.0M12.5M10.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.8B1.9B1.8B1.6B
 
 
 
 
 
Income Taxes-369.4M-397.6M-375.4M-322.8M
 
 
 
 
 
Net Income1.4B1.5B1.5B1.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.55$0.59$0.58$0.50
 
 
 
 
 
EPS Diluted$0.55$0.59$0.58--